Home » Topics » Regulatory

Regulatory
RSS

Finacea approved for topical treatment of rosacea

Jan. 9, 2003

sNDA filed for Seroquel in acute mania associated with bipolar disorder

Jan. 8, 2003

Zovirax approved by FDA for recurrent cold sores

Jan. 8, 2003

Zyvox approved for bacterial infections in infants and children

Jan. 8, 2003

Endo submits NDA for extended-release oxymorphone

Jan. 8, 2003

Metformin XT NDA submitted for type 2 diabetes

Jan. 8, 2003

Restasis receives FDA approval

Jan. 7, 2003

Topamax sNDA submitted for migraine prevention

Jan. 7, 2003

Zindaclin receives further E.U. approvals

Jan. 7, 2003

Humira approved by FDA for RA

Jan. 3, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.